Recent Merger Obalon Therapeutics recently merged with ReShape Lifesciences Inc, presenting an opportunity to leverage combined strengths and expertise for enhanced product offerings and market penetration.

Legal Issues Legal issues surrounding Obalon Therapeutics' acquisition by ReShape Lifesciences Inc may provide a chance to offer legal services, compliance support, or strategic counsel to ensure a smooth transition and settlement.

Financial Investments Obalon Therapeutics' retirement of $5 million in long-term debt facility signifies potential financial stability, creating opportunities for financial advisory services, investment products, or strategic financial partnerships.

IPO Performance After going public, Obalon Therapeutics saw a significant increase in stock value, indicating market interest and potential for investment opportunities, financial consulting, or portfolio diversification strategies for investors.

Technology Utilization Obalon Therapeutics employs a range of tech tools, such as Google Analytics and Bootstrap, indicating potential for technology upgrades, IT solutions, digital marketing services, or software integrations to enhance operational efficiency and customer engagement.